Clinical trial
Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin…
NCT00041782 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00041782 |
|---|---|
| Title | Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients |
| Official title | Outpatient Treatment Of Deep Venous Thrombosis (DVT) Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Brookdale University Hospital Medical Center Josephine Ford Cancer Center |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neoplasms, Deep Vein Thrombosis |
| Intervention type | Drug |
| Interventions | Dalteparin (Fragmin) |
| Enrollment | 26 |
| Start date | Oct 1, 2000 |
| Primary completion | Jan 1, 2005 |
| Completion | Jan 1, 2005 |
| First posted | Jul 19, 2002 |
| Last update posted | Oct 31, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: